COVID-19 infection in a patient with Behcet's Disease
Authors: George Johnson, Alice Martha Schofield, John Kirwan, Robert Moots
Background: We are continually learning how to best manage patients testing positive for SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]. This is particularly challenging in rare autoimmune conditions, where immune system dysfunction, whether by disease or treatment, has the potential to impact on the course of COVID-19 in several ways. Case Presentation: We present the case of a 52-year-old female with Behçets Disease, treated by immunosuppressive drugs, who tested positive for COVID-19 during the first month of the pandemic in the United Kingdom. In this case a multidisciplinary team approach, involving gynecological, rheumatological, microbiological, and respiratory teams was essential in ensuring the best outcome for the patient. Conclusion: Our patient had a favorable outcome; she did not require intensive care admission and has recovered. This case supports the hypothesis that the chronic immunosuppression may confer a degree of protection against severe COVID-19 disease, potentially by mitigating the pro- inflammatory cytokine responsible for the respiratory failure seen in severe cases of the disease.
Keywords: Case report, Behcet's Disease, COVID-19, immunosuppression, autoimmune disease, multidisciplinary team
Authors
Robert Moots
Consultant Rheumatologist, Behç et’s Centre of Excellence, Aintree University Hospital Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Google Scholor Articles
Pubmed Articles
Correspondence to:
George Johnson, Histopathology Trainee, North Bristol NHS Trust, Bristol, UK georgejohnson93@googlemail.com
Publication history:
Received 14 May 2021
Revised 29 Nov 2021
Accepted 18 Dec 2021
Published online 13 Jan 2022
Published in print 13 Feb 2022
Johnson G, Schofield AM, Kirwan J, Moots R. COVID-19 infection in a patient with Behcet's Disease. EJMCR. 2022; 6(1): 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson G, Schofield AM, Kirwan J, Moots R. COVID-19 infection in a patient with Behcet's Disease. https://www.ejmcr.com/?mno=80229 [Access: April 24, 2024]. doi:
10.24911/ejmcr/173-1620567671
Johnson G, Schofield AM, Kirwan J, Moots R. COVID-19 infection in a patient with Behcet's Disease. EJMCR. 2022; 6(1): 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson G, Schofield AM, Kirwan J, Moots R. COVID-19 infection in a patient with Behcet's Disease. EJMCR. (2022), [cited April 24, 2024]; 6(1): 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson, G., Schofield, . A. M., Kirwan, . J. & Moots, . R. (2022) COVID-19 infection in a patient with Behcet's Disease. EJMCR, 6 (1), 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson, George, Alice Martha Schofield, John Kirwan, and Robert Moots. 2022. COVID-19 infection in a patient with Behcet's Disease. European Journal of Medical Case Reports, 6 (1), 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson, George, Alice Martha Schofield, John Kirwan, and Robert Moots. "COVID-19 infection in a patient with Behcet's Disease." European Journal of Medical Case Reports 6 (2022), 1-4. doi:
10.24911/ejmcr/173-1620567671
Johnson, George, Alice Martha Schofield, John Kirwan, and Robert Moots. "COVID-19 infection in a patient with Behcet's Disease." European Journal of Medical Case Reports 6.1 (2022), 1-4. Print. doi:
10.24911/ejmcr/173-1620567671
Johnson, G., Schofield, . A. M., Kirwan, . J. & Moots, . R. (2022) COVID-19 infection in a patient with Behcet's Disease. European Journal of Medical Case Reports, 6 (1), 1-4. doi:
10.24911/ejmcr/173-1620567671